We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSNC icon
2726
SS&C Technologies
SSNC
$18.6B
$9K ﹤0.01%
+311
New +$9.64K
TRST
2727
Trustco Bank Corp NY
TRST
$938M
$9K ﹤0.01%
197
+177
+885% +$6.9K
USD icon
2728
ProShares Ultra Semiconductors
USD
$2.95B
$9K ﹤0.01%
+6,048
New +$7.91K
WLFC icon
2729
Willis Lease Finance
WLFC
$1.29B
$9K ﹤0.01%
+972
New +$8.39K
HTB
2730
HomeTrust Bancshares
HTB
$848M
$9K ﹤0.01%
+339
New +$7.37K
LGF.B
2731
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$9K ﹤0.01%
+373
New +$9.52K
EQC
2732
DELISTED
Equity Commonwealth
EQC
$9K ﹤0.01%
+300
New +$8.88K
TCON
2733
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$9K ﹤0.01%
9
+4
+80% +$4.57K
KDNY
2734
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$9K ﹤0.01%
+153
New +$9.26K
NVCN
2735
DELISTED
Neovasc Inc.
NVCN
0
NH
2736
DELISTED
NantHealth, Inc
NH
$9K ﹤0.01%
+58
New +$10.3K
MN
2737
DELISTED
MANNING & NAPIER, INC.
MN
$9K ﹤0.01%
+1,134
New +$8.38K
PMBC
2738
DELISTED
Pacific Mercantile Bancorp
PMBC
$9K ﹤0.01%
1,236
+836
+209% +$5.63K
WMGI
2739
DELISTED
Wright Medical Group Inc
WMGI
$9K ﹤0.01%
+410
New +$9.54K
ACHN
2740
DELISTED
Achillion Pharmaceuticals
ACHN
$9K ﹤0.01%
2,291
+2,191
+2,191% +$11.6K
CLD
2741
DELISTED
Cloud Peak Energy Inc
CLD
$9K ﹤0.01%
1,531
-1,098
-42% -$6.63K
ATHN
2742
DELISTED
Athenahealth, Inc.
ATHN
$9K ﹤0.01%
88
-9
-9% -$967
KANG
2743
DELISTED
iKang Healthcare Group, Inc.
KANG
$9K ﹤0.01%
500
-524
-51% -$8.87K
COTV
2744
DELISTED
Cotiviti Holdings, Inc.
COTV
$9K ﹤0.01%
275
-951
-78% -$31.5K
SNAK
2745
DELISTED
Inventure Foods, Inc.
SNAK
$9K ﹤0.01%
902
+546
+153% +$4.96K
CHMT
2746
DELISTED
Chemtura Corporation
CHMT
$9K ﹤0.01%
260
+190
+271% +$6.27K
SCNB
2747
DELISTED
Suffolk Bancorp
SCNB
$9K ﹤0.01%
+207
New +$8.09K
TNGO
2748
DELISTED
Tangoe, Inc.
TNGO
$9K ﹤0.01%
1,130
-1,469
-57% -$12.1K
AEPI
2749
DELISTED
AEP Industries Inc
AEPI
$9K ﹤0.01%
80
-71
-47% -$8.05K
BKSC
2750
DELISTED
Bank of South Carolina
BKSC
$9K ﹤0.01%
473
+283
+149% +$5.25K

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.